Login / Signup

Oral factor Xa inhibitors and risk of subdural hematoma: COMPASS trial results and meta-analysis.

Luciana CataneseJohn W EikelboomJackie BoschOlga ShestakovskaKelvin NgSumiti NayarKanjana S PereraAshkan ShoamaneshMukul SharmaRobert G Hart
Published in: Neurology (2020)
NCT01776424.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • randomized controlled trial
  • open label